Hamilton Lane Advisors’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,150
Closed -$246K 67
2022
Q4
$246K Hold
29,150
0.09% 55
2022
Q3
$486K Hold
29,150
0.18% 44
2022
Q2
$429K Hold
29,150
0.17% 48
2022
Q1
$723K Hold
29,150
0.16% 46
2021
Q4
$935K Hold
29,150
0.12% 59
2021
Q3
$1.05M Buy
29,150
+18,945
+186% +$745K 0.18% 51
2021
Q2
$450K Sell
10,205
-38,485
-79% -$1.68M 0.14% 62
2021
Q1
$2.23M Buy
+48,690
New +$2.79M 0.73% 31

Other funds holding LUNG

Hamilton Lane Advisors's LUNG Position: Q1 2023 in Review

Hamilton Lane Advisors sold out of Pulmonx (LUNG) in Q1 2023, closing a stake of 29,150 shares — an estimated $246K sold.

Hamilton Lane Advisors first reported a position in LUNG in Q1 2021 and held it in 8 quarters. The position peaked at $2.23M in Q1 2021. 102 funds tracked by Wall St. Rank hold LUNG as of Q1 2023.

  • Hamilton Lane Advisors reported no remaining Pulmonx position as of Q1 2023 after selling out during the quarter.
  • Hamilton Lane Advisors sold 29,150 Pulmonx shares in Q1 2023, an estimated $246K.
  • Hamilton Lane Advisors first reported a position in Pulmonx in Q1 2021 and held it in 8 quarters.
  • Hamilton Lane Advisors's Pulmonx position peaked at $2.23M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Pulmonx as of Q1 2023.

Based on Hamilton Lane Advisors's 13F filing for Q1 2023, filed 2 May 2023.